Clinical trial
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
NCT00789399 is registered in ClinicalTrials.gov with Prairie Education and Research Cooperative as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
- Lead sponsor
- Prairie Education and Research Cooperative
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- November 19, 2009
- Completion date
- September 21, 2013
- Enrollment
- 78 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery bypass surgery, deep vein thrombosis, venous thromboembolism